 |
|
Management of Cancer During Pregnancy
Donald C. Doll, MD;
Q. Scott Ringenberg, MD;
John W. Yarbro, MD, PhD
Arch Intern Med. 1988;148(9):2058-2064.
Abstract
• Although cancer during pregnancy is Infrequent, its management is difficult for patients, their families, and their physicians. When termination of the pregnancy is unacceptable, decisions regarding the use of Irradiation and chemotherapy are complicated by the well-known high risks of abortion and fetal malformation. This risk is concentrated in the first trimester and varies with the choice of chemotherapeutic agents or combinations of agents. There is only minimal evidence of increased risk of malformation or abortion in the second or third trimester. Recent progress in cancer therapy has made cure a reasonable goal, and for some malignant neoplasms, cure is still possible even when initial therapy is modified or delayed. When cure is a reasonable goal, curative therapy should not be compromised by modification or delay. When treatment for cure or significant palliation is not possible, however, the goal should shift to protection of the fetus from damage by the injudicious use of teratogenic cancer therapy. This report will review the available data that may assist in these difficult decisions.
(Arch Intern Med 1988;148:2058-2064)
Author Affiliations
From the Division of Hematology/Medical Oncology, Department of Medicine, Harry S Truman Memorial Veterans Hospital (Dr Doll) and the University of Missouri—Columbia (Drs Doll, Ringenberg, and Yarbro).
Footnotes
Accepted for publication March 30, 1988.
Reprint requests to Department of Medicine, Harry S Truman Memorial Veterans Hospital, Columbia, MO 65201 (Dr Doll).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Appraisal of Chemotherapy Effects on Reproductive Outcome According to Animal Studies and Clinical Data
Meirow and Schiff
J Natl Cancer Inst Monogr 2005;2005:21-25.
ABSTRACT
| FULL TEXT
Successful Pregnancy and Delivery in a Patient with Chronic Myelogenous Leukemia (CML), and Management of CML with Leukapheresis during Pregnancy: a Case Report and Review of the Literature
Ali et al.
Jpn J Clin Oncol 2004;34:215-217.
ABSTRACT
| FULL TEXT
Peripheral primitive neuroectodermal tumour during pregnancy
Varveris et al.
Br. J. Radiol. 2002;75:543-547.
ABSTRACT
| FULL TEXT
Renal cell carcinoma in pregnancy
Gladman et al.
JRSM 2002;95:199-201.
FULL TEXT
Outcome Analysis of 34 Pregnancies in Women With Essential Thrombocythemia
Beressi et al.
Arch Intern Med 1995;155:1217-1222.
ABSTRACT
Fetal Outcome After In Utero Exposure to Cancer Chemotherapy
Zemlickis et al.
Arch Intern Med 1992;152:573-576.
ABSTRACT
|
